Protein kinase C signalling in leukemia

References

• Hug H, Sarre T F. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem J 1993; 291: 329–343
   PubMed Web of Science ®Google Scholar
• Ohno S, Akita Y, Konno Y, Imajoh S, Suzuki K. A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family. Cell 1988; 53: 731–741
   PubMed Web of Science ®Google Scholar
• Mackay H J, Twelves C J. Targeting the protein kinase C family: are we there yet?. Nat Rev Cancer 2007; 7: 554–562
   PubMed Web of Science ®Google Scholar
• Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 2006; 18: 276–284
   PubMed Web of Science ®Google Scholar
• Redig A J, Platanias L C. The protein kinase C (PKC) family of proteins in cytokine signalling in hematopoiesis. J Interferon Cytokine Res 2007; 27: 623–636
   PubMed Web of Science ®Google Scholar
• Puente L G, Mireau L R, Lysechko T L, Ostergaard H L. Phosphatidylinositol-3-kinase regulates PKCtheta activity in cytotoxic T cells. Mol Immunol 2005; 42: 1177–1184
   PubMed Web of Science ®Google Scholar
• Greco S, Storelli C, Marsigliante S. Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. J Endocrinol 2006; 188: 79–89
   PubMed Web of Science ®Google Scholar
• Uddin S, Sassano A, Deb D K, Verma A, Majchrzak B, Rahman A, et al. Protein kinase C-delta is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 2002; 277: 14408–14416
   PubMed Web of Science ®Google Scholar
• Wang G, Silva J, Krishnamurthy K, Tran E, Condie B G, Bieberich E. Direct binding to ceramide activates protein kinase C zeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem 2005; 280: 26415–26424
   PubMed Web of Science ®Google Scholar
• Kim S J, Chang Y Y, Kang S S, Chun J S. Phorbol ester effects in atypical protein kinase C zeta overexpressing NIH3T3 cells: possible evidence for crosstalk between protein kinase C isoforms. Biochem Biophys Res Commun 1997; 237: 336–339
   PubMed Web of Science ®Google Scholar
• DelCarlo M, Loeser R F. Chondrocyte cell death mediated by reactive oxygen species-dependent activation of PKC-betaI. Am J Physiol Cell Physiol 2006; 290: c802–c811
   PubMed Web of Science ®Google Scholar
• Lee S J, Kim D C, Choi B H, Ha H, Kim K T. Regulation of p53 by activated protein kinase C-delta during nitric oxide-induced dopaminergic cell death. J Biol Chem 2005; 281: 2215–2224
   PubMed Web of Science ®Google Scholar
• Denning M F, Wang T, Nickoloff B J, Wrone-Smith T. Protein kinase C delta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J Biol Chem 1998; 273: 29995–30002
   PubMed Web of Science ®Google Scholar
• Gavrielides M V, Frijhoff A F, Conti C J, Kazanietz M G. Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets 2004; 5: 431–443
   PubMedGoogle Scholar
• Keenan C, Kelleher D. Protein kinase C and the cytoskeleton. Cell Signal 1998; 10: 225–232
   PubMed Web of Science ®Google Scholar
• Martelli A M, Evangelisti C, Nyakern M, Manzoli F A. Nuclear protein kinase C. Biochem Biophys Acta 2006; 1761: 542–551
   PubMed Web of Science ®Google Scholar
• Maissel A, Marom M, Shtutman M, Shahaf G, Livneh E. PKCeta is localized in the Golgi, ER and nuclear envelope and translocates to the nuclear envelope upon PMA activation and serum-starvation: C1b domain and the pseudosubstrate containing fragment target PKCeta to the golgi and the nuclear envelope. Cell Signal 2006; 18: 1127–1139
   Google Scholar
• Jackson D N, Foster D A. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J 2004; 18: 627–636
   PubMed Web of Science ®Google Scholar
• Koivunen J, Aaltonen V, Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Lett 2006; 235: 1–10
   PubMed Web of Science ®Google Scholar
• Balasubramanian N, Advani S H, Zingde S M. Protein kinase C isoforms in normal and leukemic neutrophils: altered levels in leukemic neutrophils and changes during myeloid maturation in chronic myeloid leukemia. Leuk Res 2002; 26: 67–81
   PubMed Web of Science ®Google Scholar
• Hampson P, Chahal H, Khanim F, Hayden R, Mulder A, Assi L K, et al. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood 2005; 106: 1362–1368
   PubMed Web of Science ®Google Scholar
• Okhrimenko H, Lu W, Xiang C, Ju D, Blumberg P M, Gomel R, et al. Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. J Biol Chem 2005; 280: 23643–23652
   PubMed Web of Science ®Google Scholar
• Hanuaske A R, Sundell K, Lahn M. The role of protein kinase C-alpha in cancer and its modulation by the novel PKC-alpha specific inhibitor aprinocarsen. Curr Pharm Des 2004; 10: 1923–1936
   PubMed Web of Science ®Google Scholar
• Lee S J, Yoon J H, Song K S. Chrysin inhibited stem cell factor (SCF)/c-Kit complex-induced cell proliferation in human myeloid leukemia cells. Biochem Pharmacol 2007; 74: 215–225
   PubMed Web of Science ®Google Scholar
• Guzman M L, Li X, Corbett C A, Rossi R M, Bushnell T, Liesveld J L, et al. Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8). Blood 2007; 110: 4436–4444
   PubMed Web of Science ®Google Scholar
• Nakagawa R, Soh J W, Michie A M. Subversion of protein kinase C alpha signalling in hematopoietic progenitor cells results in the generation of a B-cell chronic lymphocytic leukemia-like population in vivo. Cancer Res 2006; 66: 527–534
   PubMed Web of Science ®Google Scholar
• Fabbro D, Ruetz S, Bodis S, Pruschy M, Csermak K, Man A, et al. PKC412––a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des 2000; 15: 17–28
   PubMedGoogle Scholar
• Alessi D R. The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase. FEBS Lett 1997; 402: 121–123
   PubMed Web of Science ®Google Scholar
• Grandage V L, Everington T, Linch D C, Khwaja A. Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. Br J Haematol 2006; 135: 303–316
   PubMed Web of Science ®Google Scholar
• Abrams S T, Lakum T, Lin K, Jones G M, Treweeke A T, Farahani M, et al. B-cell receptor signalling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CbetaII. Blood 2007; 109: 1193–1201
   PubMed Web of Science ®Google Scholar
• Slupsky J R, Kamiguti A S, Harris R J, Cawley J C, Zuzel M. Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia. Am J Pathol 2007; 170: 745–754
   PubMed Web of Science ®Google Scholar
• Nakatake M, Kakiuchi Y, Sasaki N, Murakami-Murofushi K, Yamada O. STAT3 and PKC differentially regulate telomerase activity during megakaryocytic differentiation of K562 cells. Cell Cycle 2007; 6: 1496–1501
   PubMed Web of Science ®Google Scholar
• Choi H J, Park Y G, Kim C H. Lactosylceramide alpha2,3-sialyltransferase is induced via a PKC/ERK/CREB-dependent pathway in K562 human leukemia cells. Mol Cells 2007; 23: 138–144
   PubMed Web of Science ®Google Scholar
• Jacquel A, Herrant M, Defamie V, Belhacene N, Colosetti P, Marchetti S, et al. A survey of the singaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 2006; 25: 781–794
   PubMed Web of Science ®Google Scholar
• Hu L Y, Tepper C G, Lo S H, Lin W C. An efficient strategy to identify early TPA-responsive genes during differentiation of HL-60 cells. Gene Expr 2006; 13: 179–189
   PubMed Web of Science ®Google Scholar
• Matsumoto E, Hatanaka M, Bohgaki M, Maeda S. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells. Kobe J Med Sci 2006; 52: 81–94
   Google Scholar
• Pivoriunas A, Savickiene J, Treigyte G, Tunaitis V, Navakauskiene R, Magnusson K E. PI 3-K signalling pathway suppresses PMA-induced expression of p21WAF1/Cip1 in human leukemia cells. Mol Cell Biochem 2007; 302: 9–18
   PubMed Web of Science ®Google Scholar
• Traore K, Trush M A, George M, Spannhake E W, Anderson W, Asseffa A. Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytick leukemia THP-1 cells is reactive oxygen dependent. Leuk Res 2005; 29: 863–879
   PubMed Web of Science ®Google Scholar
• Hayun M, Okun E, Hayun R, Gafter U, Albeck M, Longo D L, et al. Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model. Leukemia 2007; 21: 1504–1513
   PubMed Web of Science ®Google Scholar
• Chou C C, Yung B Y, Hsu C Y. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells. Life Sci 2007; 80: 2051–2059
   PubMed Web of Science ®Google Scholar
• Pearn L, Fisher J, Burnett A K, Darley R L. The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood 2007; 109: 4461–4469
   PubMed Web of Science ®Google Scholar
• Kim D S, Kim S H, Song J H, Chang Y T, Hwang S Y, Kim T S. Enhancing effects of ceramide derivatives on 1,25-dihydroxyvitamin D(3)-induced differentiation of human HL-60 leukemia cells. Life Sci 2007; 81: 1638–1644
   PubMed Web of Science ®Google Scholar
• Hughes P J, Zhao Y, Chandraratna R A, Brown G. Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARalpha nad RXR and involves the phosphoinosotide 3-kinase and ERK-MAP kinase pathways. J Cell Biochem 2006; 97: 327–350
   PubMed Web of Science ®Google Scholar
• Kambhampati S, Li Y, Verma A, Sassano A, Majchrzak B, Deb D K, et al. Activation of protein kinase C delta by all-trans retinoic acid. J Biol Chem 2003; 278: 32544–32551
   PubMed Web of Science ®Google Scholar
• Vijapurkar U, Fischbach N, Shen W, Brandts C, Stokoe D, Lawrence H J, et al. Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation. Mol Cell Biol 2004; 24: 3827–3837
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Hayashi K, Nojima T, Matsuzaki Y, Kawano Y, Karasuyama H, et al. BASH-novel PKC-Raf-1 pathway of pre-BCR signalling induces kappa gene rearrangement. Blood 2006; 108: 2703–2711
   PubMed Web of Science ®Google Scholar
• Li J, Xia X, Nie H, Smith M A, Zhu X. PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562. Biochim Biophys Acta 2007; 1770: 63–70
   PubMed Web of Science ®Google Scholar
• Chow J M, Shen S C, Wu C Y, Chen Y C. 12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells. Apoptosis 2006; 11: 1999–2011
   PubMed Web of Science ®Google Scholar
• Barragan M, de Frias M, Iglesias-Serret D, Campas C, Castano E, Santidrian A F, et al. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}. J Leukoc Biol 2006; 80: 1473–1479
   PubMed Web of Science ®Google Scholar
• Perez-Chacon G, Vargas J A, Jorda J, Morado M, Rosado S, Martin-Donaire T, et al. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC. Leuk Res 2007; 31: 183–193
   PubMed Web of Science ®Google Scholar
• Alkan S, Huang Q, Ergin M, Denning M F, Nad S, Maududi T, et al. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Am J Hematol 2005; 79: 97–106
   PubMed Web of Science ®Google Scholar
• Despouy G, Joiner M, Le Toriellec E, Weil R, Stern M H. The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKC{theta} and ERK pathways. Blood 2007; 110: 4406–4416
   PubMed Web of Science ®Google Scholar
• Felli M P, Vacca A, Calce A, Bellavia D, Campese A F, Grillo R, et al. PKC theta mediates pre-TCR signalling and contributes to Notch3-induced T-cell leukemia. Oncogene 2005; 24: 992–1000
   PubMed Web of Science ®Google Scholar
• Aires V, Hichami A, Filomenko R, Plé A, Rébé C, Bettaieb A, et al. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase Cgamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol Pharmacol 2007; 72: 1545–1556
   PubMed Web of Science ®Google Scholar
• Grandage V L, Everington T, Linch D C, Khwaja A. Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. Br J Haematol 2006; 135: 303–316
   PubMed Web of Science ®Google Scholar
• Uddin S, Sassano A, Deb D K, Verma A, Majchrzak B, Rahman A, et al. J Biol Chem 2002; 277: 14408–14416
   PubMed Web of Science ®Google Scholar
• Kwon M J, Yao Y, Walter M J, Holtzman M J, Chang C H, et al. Role of PKC-delta in IFN-gamma-inducible CHTA gene expression. Mol Immunol 2007; 44(11)2841–2849
   PubMed Web of Science ®Google Scholar
• Kaur S, Parmar S, Smith J, Katsoulidis E, Li Y, Sassano A, et al. Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Exp Hematol 2005; 33: 550–557
   PubMed Web of Science ®Google Scholar
• Castro-Galache M D, Menéndez-Gutiérrez M P, Garcia E C, Garcia-Morales P, Martinez-Lacaci I, Saceda M, et al. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. Int J Biochem Cell Biol 2007; 39: 1877–1885
   PubMed Web of Science ®Google Scholar
• Kornblau S M, Qiu Y H, Bekele B N, Cade J S, Zhou X, Harris D, et al. Studying the right cell in acute myelogenous leukemia: dynamic changes of apoptosis and signal transduction pathway protein expression in chemotherapy resistant ex-vivo selected “survivor cells”. Cell Cycle 2006; 5: 2769–2777
   PubMed Web of Science ®Google Scholar
• Wang W L, Yeh S F, Huang E Y, Lu Y L, Wang C F, Huang C Y, et al. Mitochondrial anchoring of PKCalpha by PICK1 confers resistance to etoposide-induced apoptosis. Apoptosis 2007; 12: 1857–1871
   PubMed Web of Science ®Google Scholar
• Shin S Y, Kim C G, Ko J, Min D S, Change J S, Ohba M, et al. Transcriptional and post-transcriptional regulation of the PKC delta gene by etoposide in L1210 murine leukemia cells: implication of PKC delta autoregulation. J Mol Biol 2004; 340: 681–693
   PubMed Web of Science ®Google Scholar
• Fernández Calotti P, Galmarini C M, Cañones C, Gamberale R, Saénz D, Avalos J S, et al. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia. Biochem Pharmacol 2008; 75: 857–865
   PubMed Web of Science ®Google Scholar
• Panaretakis T, Laane E, Pokrovskaja K, Bjorklund A C, Moustakas A, Zhivotovsky B, et al. Doxorubicin requires the sequential actiation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. Mol Biol Cell 2005; 16: 3821–3831
   PubMed Web of Science ®Google Scholar
• Jorgensen H G, Allan E K, Mountford J C, Richmond L, Harrison S, Elliott M A, et al. Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate. Exp Hematol 2005; 33: 1140–1146
   PubMed Web of Science ®Google Scholar
• Thomas A, Pepper C, Hoy T, Bentley P. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells. Leuk Lymphoma 2004; 45: 997–1008
   PubMed Web of Science ®Google Scholar
• Li S, Phong M, Lahn M, Brail L, Sutton S, Lin B K, et al. Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas. Biol Direct 2007; 2: 8
   PubMed Web of Science ®Google Scholar
• Kurinna S, Konopleva M, Palla S L, Chen W, Kornblau S, Contractor R, et al. Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML. Leukemia 2006; 20: 1316–1319
   PubMed Web of Science ®Google Scholar